Health Costs

Health Care Affordability

BTD Health Policy in 2026

Health Policy in 2026

In a new column, President and CEO Dr. Drew Altman forecasts eight things to look for in health policy in 2026. “First and foremost,” he writes, “is the role health care affordability will play in the midterms.” And, he notes: “The average cost of a family policy for employers could approach $30,000 and cost sharing and deductibles will rise again after plateauing for several years.”

View all of Drew’s Beyond the Data Columns

Enhanced Premium Tax Credits

KEY RESOURCES
  • Health Policy 101: Costs and Affordability

    This Health Policy 101 chapter explores trends in health care costs in the U.S. and the factors that contribute to this spending. It also examines how health care spending varies and the impact on affordability and people's overall financial vulnerability.  


  • Americans’ Challenges with Health Care Costs

    This data note reviews our recent polling data that finds that Americans struggle to afford many aspects of health care, including disproportionate shares of uninsured adults, Black and Hispanic adults and those with lower incomes.

  • National Health Spending Explorer

    This interactive Peterson-KFF Health System Tracker tool allows users to examine five decades worth of data on health expenditures by federal and local governments, private insurers, and individuals.

  • Polling on Prescription Drugs and Their Prices

    This chart collection draws on recent KFF poll findings to provide an in-depth look at the public’s attitudes toward prescription drugs and their prices. Results include Americans’ opinions on drug affordability, pharmaceutical companies, and various potential measures that could lower prices.

Subscribe to KFF Emails

Choose which emails are best for you.
Sign up here

Filter

751 - 760 of 1,540 Results

  • Why Consumer Issues Are Rising on the Health Agenda

    News Release

    In his latest column for The Wall Street Journal’s Think Tank, Drew Altman examines the trends that may be leading to a rise in consumer cost issues on the health agenda. All previous columns by Drew Altman are available online.

  • 2015 Employer Health Benefits Survey

    Feature

    This annual Employer Health Benefits Survey (EHBS) provides a detailed look at trends in employer-sponsored health coverage, including premiums, employee contributions, cost-sharing provisions, and other relevant information. The 2015 EHBS survey finds average family health premiums rose 4 percent in 2015, relatively modest growth by historical standards.

  • Web Briefing for Media: 2015 Kaiser/HRET Employer Health Benefits Survey

    Event Date:
    Event

    The Kaiser Family Foundation and the Health Research & Educational Trust (HRET) hosts an annual reporters-only web briefing to release the 2015 Kaiser/HRET Employer Health Benefits Survey. The 17th annual Kaiser/HRET survey provides a detailed look at the current state of employer-based coverage and trends in private health insurance, including premiums, worker and employer contributions, firm offer rates, plan deductibles, and other cost-sharing requirements, with breakouts for small and large firms.

  • Measuring the Quality of Healthcare in the U.S.

    Issue Brief

    The quality of the U.S. health system is improving in many areas, but comparable countries continue to outperform the United States on key measures. In this brief on the Peterson-Kaiser Health System Tracker, analysts from the Kaiser Family Foundation compile an overall picture of health care quality in the United States, using the best available data from numerous sources on health outcomes, quality of care, and access to services.

  • Why Higher Drug Costs Are Consumers’ Biggest Cost Worry

    News Release

    In his latest column for The Wall Street Journal's Think Tank, Drew Altman discusses why public concern over drug prices is the “tip of the iceberg” representing broader concerns about out-of-pocket health care costs. All previous columns by Drew Altman are available online.

  • Why Higher Drug Costs Are Consumers’ Biggest Cost Worry

    From Drew Altman

    In this column for The Wall Street Journal's Think Tank, Drew Altman discusses why public concern over drug prices is the “tip of the iceberg” representing broader concerns about out-of-pocket health care costs.